Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertensive Patients

NCT01987323 is registered in ClinicalTrials.gov with Singapore Eye Research Institute as lead sponsor.

NCT NCT01987323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01987323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertensive Patients
Lead sponsor
Singapore Eye Research Institute
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2013
Completion date
June 30, 2013
Enrollment
6 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension